PRRT2 and allergic asthma: Studies have shown that PKCθ-/- mice fail to develop experimental allergic encephalomyelitis (EAE) and display drastically reduced lung inflammation after the induction of allergic asthma and alloreactivity in TX medicine, suggesting that PKCθ by itself is an attractive monotarget for modulation of the immune response.